The return of RSV during the COVID‐19 pandemic

Ferrero, Fernando; Ossorio, María Fabiana; Rial, María José

doi:10.1002/ppul.25802

Cited by 19 publications

(19 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, when the data from the CDC were analyzed, we found an unchanged flu vaccine acceptance rate since the pandemic outbreak. A sudden uptrend in RSV during COVID-19 was previously reported, mostly from regional hospitals [ 17 , 31 ]. In contrast, our study comprehensively summarized statistics from a national database.…”

Section: Discussionmentioning

confidence: 99%

The Influence of COVID-19 on Influenza and Respiratory Syncytial Virus Activities

Mondal

Sinharoy

Gope

2022

Infectious Disease Reports

View full text Add to dashboard Cite

Background: Respiratory viral diseases have considerably declined since the COVID-19 outbreak, perhaps through influence by nonpharmaceutical interventions. We conducted a cross-sectional study using the CDC database to compare the pre- vs. post-pandemic flu activity (incidence) between the US states. Our secondary objectives were to estimate the association between flu activity and flu vaccination rates and compare the national trends of flu and RSV activities since the pandemic outbreak. Methods: We estimated the difference between pre-pandemic (April 2019–March 2020) and post-pandemic (April 2020–March 2021) flu activity between individual states using the Wilcoxon signed-rank test. The association between flu activity and immunization rates was also measured. Finally, parallel time trend graphs for flu and RSV activities were illustrated with a time series modeler. Results: The median (IQR) pre-pandemic flu activity was 4.10 (1.38), higher than the post-pandemic activity (1.38 (0.71)) (p-value < 0.001). There was no difference between pre-pandemic (45.50% (39.10%)) and post-pandemic (45.0% (19.84%)) flu vaccine acceptance (p-value > 0.05). Flu activity and vaccination rates were not associated (p-value > 0.05). Flu activity has declined since the COVID-19 outbreak, while RSV made a strong comeback in June 2021. Conclusion: Flu activity has significantly diminished throughout the pandemic while a sudden upsurge in RSV is a public health concern indicative of possible resurgence of other viruses. Flu vaccine acceptance neither changed during the pandemic nor influenced the diminished Flu activity.

show abstract

Section: Discussionmentioning

confidence: 99%

The Influence of COVID-19 on Influenza and Respiratory Syncytial Virus Activities

Mondal

Sinharoy

Gope

2022

Infectious Disease Reports

View full text Add to dashboard Cite

show abstract

“…recently reported that, at the beginning of the COVID-19 pandemic, the usual winter 2020/2021 Respiratory Syncytial Virus (RSV) peak did not occur in Oxfordshire, UK, with an inter-seasonal rise several months later, 1 as described worldwide. 2 , 3 , 4 , 5 , 6 We previously described, in our French tertiary hospital, that the delayed RSV 2020/2021 outbreak involved less adults and was associated with more hospitalization, higher age of pediatric inpatients and milder median clinical phenotype than observed before the COVID-19 pandemic. 2 In France, severe public restrictions (national lockdown, curfew) ended in May-June 2021, but some measures have been maintained (universal masking policy in adults and children ≥6 years in healthcare settings, schools, public transportations and most indoor spaces, educational interventions for prevention of community and healthcare-associated respiratory infections).…”

mentioning

confidence: 91%

No durable impact of COVID-19 measures on the hospital burden of respiratory syncytial virus (France, 2018–2022)

Fourgeaud

Toubiana

Chappuy

et al. 2022

Journal of Infection

View full text Add to dashboard Cite

“…3,6 These findings are consistent with reports made in similar epidemiological conditions, which indicated an increase in prevalence after the return to school. 10,11 In Argentina, this was already reported among hospitalized patients in the winter of 2021, 12 although few studies have been conducted in outpatients.…”

Section: Discussionmentioning

confidence: 91%

Screening for common respiratory viruses in pediatric outpatients 2 years after the onset of the COVID-19 pandemic

et al. 2022

View full text Add to dashboard Cite

Introduction. During 2020, circulation of other respiratory viruses was lower than usual. Most likely, as mitigation measures for coronavirus disease 2019 (COVID-19) were modified, their prevalence in 2021 may have increased. Objective. To estimate the prevalence of common respiratory viruses among patients aged 0-5 years seen at the Emergency Department of a children's hospital in the City of Buenos Aires. Methods. Cross-sectional study of 348 patients consulting for suspected COVID-19 in whom SARS-CoV-2 infection was ruled out and routine screening for common respiratory viruses was performed. Results. Respiratory syncytial virus (RSV), a common respiratory virus, was identified in 40% of patients. Age younger than 2 years was an independent predictor of RSV (odds ratio [OR]: 4.15; 95% confidence interval [CI]: 2.46-6.99). Conclusion. In the study population, 40% of patients suspected of COVID-19 in whom SARS-CoV-2 infection was ruled out had RSV infection.

show abstract

The return of RSV during the COVID‐19 pandemic

Cited by 19 publications

References 5 publications

The Influence of COVID-19 on Influenza and Respiratory Syncytial Virus Activities

The Influence of COVID-19 on Influenza and Respiratory Syncytial Virus Activities

No durable impact of COVID-19 measures on the hospital burden of respiratory syncytial virus (France, 2018–2022)

Screening for common respiratory viruses in pediatric outpatients 2 years after the onset of the COVID-19 pandemic

Contact Info

Product

Resources

About